SCHEMBL19785408

SCHEMBL19785408

CC(=O)CCC(=O)NCc1ccc2ccc3cccc4ccc1c2c34

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
KDM4E B2RXH2 5/20 0.46
HPGD P15428 5/20 0.46
ALDH1A1 P00352 4/20 0.46
MAPT P10636 1/20 0.46
FAAH O00519 1/20 0.44
TERT O14746 2/20 0.42
POLB P06746 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP1A2 P05177 1/20 0.40
GLA P06280 1/20 0.40
CYP2D6 P10635 1/20 0.40
NQO2 P16083 1/20 0.40
ITPR1 Q14643 1/20 0.38
F10 P00742 1/20 0.38
CYP3A4 P08684 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20422761 0.89 KMT2A (0.49) KMT2AMEN1KDM4EHPGDALDH1A1
SCHEMBL14940077 0.84 KMT2A (0.67) KMT2AMEN1KDM4EHPGDALDH1A1
SCHEMBL12571772 0.84 KMT2A (0.50) KMT2AMEN1KDM4EHPGDALDH1A1
SCHEMBL14940250 0.84 KMT2A (0.53) KMT2AMEN1KDM4EHPGDALDH1A1
SCHEMBL27931462 0.84 ALDH1A1 (0.55) KMT2AMEN1KDM4EHPGDALDH1A1
SCHEMBL21615671 0.84 EPHX2 (0.51) KMT2AMEN1FAAHHTTMTNR1A
SCHEMBL24700650 0.82 KMT2A (0.48) KMT2AMEN1KDM4EHPGDALDH1A1
SCHEMBL2009382 0.81 KMT2A (0.50) KMT2AMEN1KDM4EHPGDALDH1A1
SCHEMBL1801575 0.81 KMT2A (0.50) KMT2AMEN1KDM4EHPGDALDH1A1
SCHEMBL28136252 0.80 KMT2A (0.53) KMT2AMEN1KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323127-B2 Poly(aspartic acid) derived co-polymers for a controlled release of perfuming ingredients FIRMENICH SA (CH) 2019-06-18 US disclosed
US-20180016396-A1 POLY(ASPARTIC ACID) DERIVED CO-POLYMERS FOR A CONTROLLED RELEASE OF PERFUMING INGREDIENTS FIRMENICH SA (CH) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10323127-B2 Poly(aspartic acid) derived co-polymers for a controlled release of perfuming ingredients PHGDH, PARG, ACLY KMT2A 3471/4885MEN1 4024/4885KDM4E 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.